Stratagene Shares Continue Rebound as Index Falls | GenomeWeb

Shares of Stratagene gained 9.5 percent to lead all stocks in the BCW Index for the trading week ended Tuesday. The firm's shares have risen 27 percent since hitting a 52-week low on June 27. Stratagene was only one of four companies in the Index to gain ground for the tracking period. Invitrogen and Agilent led the decliners for the week, falling 5.6 percent and 5.3 percent, respectively.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.